These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8776946)

  • 1. Squalene synthase inhibitors: their potential as hypocholesterolaemic agents.
    Watson NS; Procopiou PA
    Prog Med Chem; 1996; 33():331-78. PubMed ID: 8776946
    [No Abstract]   [Full Text] [Related]  

  • 2. Phenoxypropylamines: a new series of squalene synthase inhibitors.
    Brown GR; Butlin RJ; Chapman S; Eakin MA; Foubister AJ; Freeman S; Griffiths D; Harrison PJ; Johnson MC; Mallion KB
    J Med Chem; 1995 Oct; 38(21):4157-60. PubMed ID: 7473541
    [No Abstract]   [Full Text] [Related]  

  • 3. (1 alpha, 2 beta, 3 beta, 4 alpha)-1,2-bis[N-propyl-N-(4-phenoxybenzyl) amino]carbonyl]cyclobutane-3,4-dicarboxylic acid (A-87049): a novel potent squalene synthase inhibitor.
    Fung AK; Baker WR; Fakhoury S; Stein HH; Cohen J; Donner BG; Garvey DS; Spina KP; Rosenberg SH
    J Med Chem; 1997 Jul; 40(14):2123-5. PubMed ID: 9216829
    [No Abstract]   [Full Text] [Related]  

  • 4. The squalestatins: decarboxy and 4-deoxy analogues as potent squalene synthase inhibitors.
    Chan C; Andreotti D; Cox B; Dymock BW; Hutson JL; Keeling SE; McCarthy AD; Procopiou PA; Ross BC; Sareen M; Scicinski JJ; Sharratt PJ; Snowden MA; Watson NS
    J Med Chem; 1996 Jan; 39(1):207-16. PubMed ID: 8568810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isoprenyl phosphinylformates: new inhibitors of squalene synthetase.
    Biller SA; Forster C; Gordon EM; Harrity T; Rich LC; Marretta J; Ciosek CP
    J Med Chem; 1991 Jun; 34(6):1912-4. PubMed ID: 2061928
    [No Abstract]   [Full Text] [Related]  

  • 6. Discovery of novel tricyclic compounds as squalene synthase inhibitors.
    Ichikawa M; Ohtsuka M; Ohki H; Haginoya N; Itoh M; Sugita K; Usui H; Suzuki M; Terayama K; Kanda A
    Bioorg Med Chem; 2012 May; 20(9):3072-93. PubMed ID: 22464687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of quinuclidine derivatives incorporating phenothiazine moieties as squalene synthase inhibitors.
    Ishihara T; Kakuta H; Moritani H; Ugawa T; Yanagisawa I
    Chem Pharm Bull (Tokyo); 2004 Oct; 52(10):1204-9. PubMed ID: 15467236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of atrop fixed alkoxy-aminobenzhydrol derivatives: novel, highly potent and orally efficacious squalene synthase inhibitors.
    Ichikawa M; Yokomizo A; Itoh M; Haginoya N; Sugita K; Usui H; Terayama K; Kanda A
    Bioorg Med Chem; 2011 Sep; 19(17):5207-24. PubMed ID: 21802309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The squalestatins: novel inhibitors of squalene synthase. Enzyme inhibitory activities and in vivo evaluation of C1-modified analogues.
    Procopiou PA; Bailey EJ; Bamford MJ; Craven AP; Dymock BW; Houston JG; Hutson JL; Kirk BE; McCarthy AD; Sareen M
    J Med Chem; 1994 Sep; 37(20):3274-81. PubMed ID: 7932554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipophilic 1,1-bisphosphonates are potent squalene synthase inhibitors and orally active cholesterol lowering agents in vivo.
    Ciosek CP; Magnin DR; Harrity TW; Logan JV; Dickson JK; Gordon EM; Hamilton KA; Jolibois KG; Kunselman LK; Lawrence RM
    J Biol Chem; 1993 Nov; 268(33):24832-7. PubMed ID: 8227045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Syntheses and biological evaluation of novel quinuclidine derivatives as squalene synthase inhibitors.
    Ishihara T; Kakuta H; Moritani H; Ugawa T; Sakamoto S; Tsukamoto S; Yanagisawa I
    Bioorg Med Chem; 2003 May; 11(11):2403-14. PubMed ID: 12735986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Squalene synthase inhibitor lapaquistat acetate: could anything be better than statins?
    Liao JK
    Circulation; 2011 May; 123(18):1925-8. PubMed ID: 21518979
    [No Abstract]   [Full Text] [Related]  

  • 13. The squalestatins: inhibitors of squalene synthase. Enzyme inhibitory activities and in vivo evaluation of C3-modified analogues.
    Procopiou PA; Cox B; Kirk BE; Lester MG; McCarthy AD; Sareen M; Sharratt PJ; Snowden MA; Spooner SJ; Watson NS; Widdowson J
    J Med Chem; 1996 Mar; 39(7):1413-22. PubMed ID: 8691471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RPR 107393, a potent squalene synthase inhibitor and orally effective cholesterol-lowering agent: comparison with inhibitors of HMG-CoA reductase.
    Amin D; Rutledge RZ; Needle SN; Galczenski HF; Neuenschwander K; Scotese AC; Maguire MP; Bush RC; Hele DJ; Bilder GE; Perrone MH
    J Pharmacol Exp Ther; 1997 May; 281(2):746-52. PubMed ID: 9152381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of 4H,6H-[2]benzoxepino[4,5-c][1,2]oxazoles as novel squalene synthase inhibitors.
    Griebenow N; Buchmueller A; Kolkhof P; Schamberger J; Bischoff H
    Bioorg Med Chem Lett; 2011 Jun; 21(12):3648-53. PubMed ID: 21576018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery, biosynthesis, and mechanism of action of the zaragozic acids: potent inhibitors of squalene synthase.
    Bergstrom JD; Dufresne C; Bills GF; Nallin-Omstead M; Byrne K
    Annu Rev Microbiol; 1995; 49():607-39. PubMed ID: 8561474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Squalene synthase inhibitors : clinical pharmacology and cholesterol-lowering potential.
    Charlton-Menys V; Durrington PN
    Drugs; 2007; 67(1):11-6. PubMed ID: 17209661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclopentanedi- and tricarboxylic acids as squalene synthase inhibitors: syntheses and evaluation.
    Shen W; Garvey DS; Cohen J; Stein H; Rosenberg SH
    Bioorg Med Chem Lett; 1998 Apr; 8(8):891-6. PubMed ID: 9871507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of novel mammalian squalene synthase inhibitors using a three-dimensional pharmacophore.
    Fairlamb IJ; Dickinson JM; O'Connor R; Higson S; Grieveson L; Marin V
    Bioorg Med Chem; 2002 Aug; 10(8):2641-56. PubMed ID: 12057653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and optimization of tetrahydro-2H-3-benzazepin-2-ones as squalene synthase inhibitors.
    Griebenow N; Flessner T; Buchmueller A; Raabe M; Bischoff H; Kolkhof P
    Bioorg Med Chem Lett; 2011 Apr; 21(8):2554-8. PubMed ID: 21396815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.